Ahmad Al-Khleifat

The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

Timothy A. Miller, A. Al-Chalabi, C. Shaw, 2022, Nature Communications.

Molecular dynamics analysis of Superoxide Dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression

Timothy A. Miller, R. Dobson, A. Al-Chalabi, 2022, bioRxiv.

SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed

Ashley R. Jones, G. Breen, A. Al-Chalabi, 2021, Brain communications.

UK case control study of smoking and risk of amyotrophic lateral sclerosis

N. Pearce, A. Al-Chalabi, G. Davey-Smith, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ALSUntangled 53: Carnitine supplements

Marios, A. Al-Chalabi, G. Davey-Smith, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseases

E. Elhaik, E. Hornstein, K. Kenna, 2024, bioRxiv.